Skip to content
A Green Sign – Lifestyle
Author:
IMPACT Therapeutics
IMPACT Therapeutics Signs Exclusive License Agreement with Pharmanovia for Senaparib in Europe, Middle East and North Africa, Australia and New Zealand
July 31, 2026